Civic Intelligence

Global Solutions for Infectious Diseases

990 • Fiscal year 2016 • EIN 20-0941177

Jan 01, 2016 to Dec 31, 2016 • Filed on Aug 23, 2017

830 Dubuque AvenueSouth San Francisco, CA 94080

(650) 228-7908

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.08x

Higher debt load relative to assets than 47% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Liabilities / Revenue

26th percentile

0.02x

Higher debt load relative to revenue than 26% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Net Margin

56th percentile

4.1%

Higher net margin than 56% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Top Officer Pay

91st percentile

$215,939

Higher top officer pay than 91% of similar nonprofits.

Top officer pay equals 12.4% of source-year revenue.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Asset Growth

80th percentile

17%

Faster asset growth than 80% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Revenue Growth

56th percentile

5.3%

Faster revenue growth than 56% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Assets

Up

$487,411

Up $70,583 (+17%) from 2015

Net Assets

Up

$448,262

Up $71,746 (+19%) from 2015

Liabilities

Down

$39,149

Down $1,163 (-2.9%) from 2015

Revenue

Up

$1,745,170

Up $87,224 (+5.3%) from 2015

Expenses

Down

$1,673,424

Down $92,043 (-5.2%) from 2015

Net Income

Up

$71,746

Up $179,267 (+167%) from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2010: $653,551Liabilities 2010: $61,974Net Assets 2010: $591,5772010Assets 2011: $718,514Liabilities 2011: $64,352Net Assets 2011: $654,1622011Assets 2012: $457,105Liabilities 2012: $37,311Net Assets 2012: $419,7942012Assets 2013: $568,786Liabilities 2013: $38,311Net Assets 2013: $530,4752013Assets 2014: $532,428Liabilities 2014: $48,391Net Assets 2014: $484,0372014Assets 2015: $416,828Liabilities 2015: $40,312Net Assets 2015: $376,5162015Assets 2016: $487,411Liabilities 2016: $39,149Net Assets 2016: $448,2622016Assets 2017: $483,862Liabilities 2017: $8,562Net Assets 2017: $475,3002017Assets 2018: $407,572Liabilities 2018: $9,439Net Assets 2018: $398,1332018Assets 2019: $252,856Liabilities 2019: $7,875Net Assets 2019: $244,9812019Assets 2020: $351,151Liabilities 2020: $8,323Net Assets 2020: $342,8282020Assets 2021: $609,139Liabilities 2021: $5,640Net Assets 2021: $603,4992021Assets 2022: $528,108Liabilities 2022: $5,760Net Assets 2022: $522,3482022Assets 2023: $539,017Liabilities 2023: $3,755Net Assets 2023: $535,2622023Assets 2024: $206,881Liabilities 2024: $0Net Assets 2024: $206,8812024Assets 2025: $0Liabilities 2025: $0Net Assets 2025: $02025

Highlighted filing

2016

Assets$487,411
Liabilities$39,149
Net Assets$448,262

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2010: $2,184,040Expenses 2010: $2,526,758Net Income 2010: -$342,7182010Revenue 2011: $1,792,208Expenses 2011: $1,729,623Net Income 2011: $62,5852011Expenses 2012: $1,537,1392012Revenue 2013: $1,980,374Expenses 2013: $1,869,693Net Income 2013: $110,6812013Revenue 2014: $1,696,287Expenses 2014: $1,742,725Net Income 2014: -$46,4382014Revenue 2015: $1,657,946Expenses 2015: $1,765,467Net Income 2015: -$107,5212015Revenue 2016: $1,745,170Expenses 2016: $1,673,424Net Income 2016: $71,7462016Revenue 2017: $1,716,690Expenses 2017: $1,689,652Net Income 2017: $27,0382017Revenue 2018: $1,439,966Expenses 2018: $1,517,133Net Income 2018: -$77,1672018Revenue 2019: $926,380Expenses 2019: $1,079,532Net Income 2019: -$153,1522019Revenue 2020: $1,128,778Expenses 2020: $1,038,942Net Income 2020: $89,8362020Revenue 2021: $1,338,688Expenses 2021: $1,059,111Net Income 2021: $279,5772021Revenue 2022: $961,683Expenses 2022: $1,042,834Net Income 2022: -$81,1512022Revenue 2023: $809,948Expenses 2023: $797,034Net Income 2023: $12,9142023Revenue 2024: $16,765Expenses 2024: $345,146Net Income 2024: -$328,3812024Revenue 2025: $1,463Expenses 2025: $101,338Net Income 2025: -$99,8752025

Highlighted filing

2016

Revenue$1,745,170
Expenses$1,673,424
Net Income$71,746
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Aug 23, 2017
Return Version
2016v3.1
Gross Receipts
$1,745,170
Mission and Program Overview

Mission

The mission of gsid is to expand the development of low-cost effective tools for the diagnosis and prevention of infectious diseases afflicting less developed countries.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$-29,152$243,844▲ $272,996
Pledges and Grants Receivable$316,897$132,135▼ $184,762
Savings and Temporary Cash Investments$25,000$0▼ $25,000
Land, Buildings, and Equipment, Net$22,583$24,174▲ $1,591
Prepaid Expenses and Deferred Charges$0$5,758▲ $5,758
Accounts Receivable$0$0→ $0
Other Notes and Loans Receivable, Net$0$0→ $0
Receivable From Disqualified Prsn$0$0→ $0
Receivables From Officers Etc$0$0→ $0
Investments Other Securities$0$0→ $0
Investments Program Related$0$0→ $0
Investments in Publicly Traded Securities$0$0→ $0
Intangible Assets$0$0→ $0
Inventories for Sale or Use$0$0→ $0
Loans From Officers Directors$0$0→ $0
Total Assets$416,828$487,411▲ $70,583
Other Assets Total$81,500$81,500→ $0
Liabilities
Deferred Revenue$0$20,016▲ $20,016
Accounts Payable and Accrued Expenses$40,312$10,853▼ $29,459
Other Liabilities$0$8,280▲ $8,280
Grants Payable$0$0→ $0
Mortgage Notes Payable Secured by Investment Property$0$0→ $0
Unsecured Notes Loans Payable$0$0→ $0
Escrow Account Liability$0$0→ $0
Tax Exempt Bond Liabilities$0$0→ $0
Total Liabilities$40,312$39,149▼ $1,163
Net Assets / Fund Balance
Temporarily Rstr Net Assets$376,516$448,262▲ $71,746
Permanently Rstr Net Assets$0$0→ $0
Unrestricted Net Assets$0$0→ $0
Total Net Assets Fund Balance$376,516$448,262▲ $71,746
Total Liabilities and Net Assets / Fund Balance$416,828$487,411▲ $70,583

Asset Categories

AssetBook ValueDepreciationBasis
Leasehold Improvements$2,000$484,962$486,962
Equipment$21,067$174,147$195,214
Other Land Buildings$1,107$12,176$13,283
Other Assets Org$81,500--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Vineeta G GulatiDirector, Clinical Ops & RegFT$169,500$46,439$215,939
Carter A LeeExecutive DirectorFT$204,000$9,665$213,665
Faruk M SinangilDirector Research CollaborationsFT$168,000$14,231$182,231
Keith W HigginsProg Coor & Repository MgrFT$147,000$31,154$178,154
Lavon L RiddleDirector of ManufacturingPT$120,000$17,523$137,523
Donald P FrancisExecutive Director--$460$460

Board Members and Trustees

NameTitle
Dr Seung-Il ShinDirector

Highest Paid Contractors

ContractorServicesLocationCompensation
None---
Revenue and Support

Revenue Composition

Contributions and Grants
$1,735,156
Program Service Revenue
$10,000
Investment Income
$14
Other Revenue
$0
All Other Contributions
$1,735,156
Change in Net Assets
$71,746
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,029,990
Other Expenses$643,434
Total Fundraising Expense$122,685
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$569,865$32,983$32,983$635,831
Current Officers, Directors, Trustees, and Key Employees$107,063$53,531$53,531$214,125
Occupancy$155,855$18,268$18,268$192,391
Fees for Services Other$168,738$4,628-$173,366
Insurance$109,937$9,652-$119,589
Other Employee Benefits$82,799$9,981$9,981$102,761
Payroll Taxes$41,467$5,183$5,183$51,833
Information Technology-$26,579$1,419$27,998
Pension Plan Contributions$22,800$1,320$1,320$25,440
Travel$18,053$2,963-$21,016
Office Expenses$8,797$8,618-$17,415
Fees for Services Accounting-$16,196-$16,196
Depreciation Depletion-$6,900-$6,900
Other Expenses$6,894$2,143-$6,894
Fees for Services Legal$3,195$3,591-$6,786
Conferences and Meetings$1,725--$1,725
All Other Expenses$23$154-$177
Total Functional Expenses$1,346,342$204,397$122,685$1,673,424
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$0
Fundraising Gross Income$0
Gaming Direct Expenses$0
Gaming Gross Income$0
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Receivables from Disqualified Persons$0$0→ $0
Receivables from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Accrued 401k Match$8,280
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Part VI, Section B, Line 11A & 11B

Prior to filing, a complete copy of the final form 990 was distributed to all voting board members who reviewed and discussed the return. The discussion was formalized in the board minutes and a resolution was proposed and voted upon to document the review and give authorization to the deputy executive director to file the return with the internal revenue service.

Part VI, Section B, Line 12C

The Board is charged with monitoring proposed or ongoing transactions for conflicts of interest and addressing any potential or actual conflicts. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire, aimed at determining any family and business relationships and transactions or other transactions that may pose a potential conflict, is distributed to all covered persons (i.e., board members, officers and executive leadership or key employees). Covered persons are required to disclose real or potential conflicts at the time when such conflicts arise. When someone becomes a covered person and annually thereafter, each covered person is required to sign a statement affirming that he/she: (1) has received a copy of the Conflict of Interest Policy; (2) has read the Policy and understands said Policy; and (3) agrees to comply with all requirements of the Policy, including completing the conflict of interest questionnaire. The completed questionnaires are reviewed by the Board and any persons with actual or potential conflicts are informed via written communication. The procedures for addressing any conflict of interest includes, but is not limited to, the following: (1) the conflicting interest is fully disclosed to the Board; (2) the interested person responds to factual questions related to the substance of the transaction or arrangement being considered, after which he/she shall leave the meeting; (3) the person with the conflict of interest is excluded from the discussion and approval of such transaction; (4) alternatives to the proposed transaction are investigated, competitive bids or comparable valuations are obtained; and (5) the transaction or action must be approved by a majority of disinterested persons.

Part VI Section B Line 13

Whistleblower Policy GSID is a scientifically-based organization which encourages open communication and the exchange of ideas and opinions. Because it is a small organization, it does not believe it is necessary to implement a formal whistleblower policy.

Part VI, Section B, line 15

COMPENSATION POLICY Compensation of the organization's two officers is decided upon and approved by the board of directors. The board utilizes industry data to determine salary levels and increases. Because the organizations two internal directors are also active officers, the director cannot approve his salary and therefore must recuse himself from the board action. The external board member is always included in the compensation approval process.

Part VI, Section C, Line 19

Dissemination of Financial GSID makes its financial information available upon request.

Filing and Contact Details

Filer

Filer Name
Global Solutions for Infectious Diseases
EIN
20-0941177
In Care Of
% CARTER A LEE
Phone
6502287908
Address
830 Dubuque Avenue, South San Francisco, CA 94080

Signing Officer

Name
Carter a Lee
Title
Executive Director
Signed
2017-08-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Carter a Lee
Formed
2004
Legal Domicile
CA
Voting Board Members
3
Independent Board Members
1
Employees
6
Volunteers
2

Preparer

Firm
Kpmg Llp
Address
55 Second Street 1400, San Francisco, CA 94105
Preparer
Valerie J Ball
Phone
4159635100
Supplemental Narrative

Additional Explanations

Form 990 Part IX Line 11G

Description:stability testing total fees:71583

Form 990 Part IX Line 11G

Description:potein characterization total fees:40520

Form 990 Part IX Line 11G

Description:consultant fees total fees:29137

Form 990 Part IX Line 11G

Description:neutralization assays total fees:14063

Form 990 Part IX Line 11G

Description:software development total fees:13435

Form 990 Part IX Line 11G

Description:payroll processing total fees:2002

Form 990 Part IX Line 11G

Description:benefits administration total fees:2626

Raw XML AppendixShowing 400 of 593 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt040312
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt010853
IRS990/AccountsReceivableGrp/BOYAmt00
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0the mission of GSID is to expand the development of low-cost effective tools for the diagnosis and prevention of infectious diseases afflicting less developed countries.
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllOtherContributionsAmt01735156
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0154
IRS990/AllOtherExpensesGrp/ProgramServicesAmt023
IRS990/AllOtherExpensesGrp/TotalAmt0177
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0CARTER A LEE
IRS990/BooksInCareOfDetail/PhoneNum06502287908
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0830 DUBUQUE AVENUE
IRS990/BooksInCareOfDetail/USAddress/CityNm0South San Francisco
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094080
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0-29152
IRS990/CashNonInterestBearingGrp/EOYAmt0243844
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt053531
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt053531
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0107063
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0214125
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt01725
IRS990/ConferencesMeetingsGrp/TotalAmt01725
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContractorCompensationGrp/ContractorName/PersonNm0NONE
IRS990/CostOfGoodsSoldAmt00
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01735156
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt014
IRS990/CYOtherExpensesAmt0643434
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt010000
IRS990/CYRevenuesLessExpensesAmt071746
IRS990/CYSalariesCompEmpBnftPaidAmt01029990
IRS990/CYTotalExpensesAmt01673424
IRS990/CYTotalFundraisingExpenseAmt0122685
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01745170
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DeferredRevenueGrp/BOYAmt00
IRS990/DeferredRevenueGrp/EOYAmt020016
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt06900
IRS990/DepreciationDepletionGrp/TotalAmt06900
IRS990/Desc0GSID provided its vaccine product, AIDSVAXB/E, a vaccine designed to prevent infection from HIV-1, to several human clinical trials and non-human studies in Thailand, Switzerland, South Africa, Uganda and the United States. A primary objective of these phase I and II studies is to generate new safety and immunological data which will help design future large-scale efficacy trials planned for the next generation of HIV vaccine candidates and to gain further understanding of why a previously conducted efficacy trial was partially successful. Funding for these activities in 2016 was provided by the Henry M. Jackson Foundation (Bethesda, MD). No activities related to this program were conducted by GSID personnel in Asia or Sub-Saharan Africa during 2016. GSID established repository containing the serological specimens collected primarily from the first two phase III clinical trials of an HIV/AIDS vaccine. The repository consists of over 30 ultra-low freezer units containing over 300,000 vials of serum and plasma collected from over 8,000 volunteers who participated in the clinical trials. The specimens are provided under material transfer agreements to investigators in the scientific community who are working towards finding a better understanding of the virus that causes AIDS and to those scientists who are developing vaccines to prevent HIV infection. The repository also contains other materials such as: GMP-grade vaccine, manufacturing reagents, research-grade vaccine and data which are also provided to the research community to conduct experiments, pre-clinical trials and human clinical trials; and to develop laboratory assays.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/EscrowAccountLiabilityGrp/BOYAmt00
IRS990/EscrowAccountLiabilityGrp/EOYAmt00
IRS990/ExpenseAmt01258677
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt016196
IRS990/FeesForServicesAccountingGrp/TotalAmt016196
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt03591
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt03195
IRS990/FeesForServicesLegalGrp/TotalAmt06786
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt04628
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0168738
IRS990/FeesForServicesOtherGrp/TotalAmt0173366
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt00
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt40.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt50.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt440.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt620.0
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt0460
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt19665
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt314231
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt446439
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt531154
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt617523
IRS990/Form990PartVIISectionAGrp/PersonNm0Donald P Francis
IRS990/Form990PartVIISectionAGrp/PersonNm1Carter A Lee
IRS990/Form990PartVIISectionAGrp/PersonNm2Dr Seung-Il Shin
IRS990/Form990PartVIISectionAGrp/PersonNm3Faruk M Sinangil
IRS990/Form990PartVIISectionAGrp/PersonNm4Vineeta G Gulati
IRS990/Form990PartVIISectionAGrp/PersonNm5Keith W Higgins
IRS990/Form990PartVIISectionAGrp/PersonNm6Lavon L Riddle
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1204000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3168000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4169500
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5147000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6120000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0Executive Director
IRS990/Form990PartVIISectionAGrp/TitleTxt1Executive Director
IRS990/Form990PartVIISectionAGrp/TitleTxt2Director
IRS990/Form990PartVIISectionAGrp/TitleTxt3Dir. Research Collaborations
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR, CLINICAL OPS & REG
IRS990/Form990PartVIISectionAGrp/TitleTxt5PROG COOR & REPOSITORY MGR
IRS990/Form990PartVIISectionAGrp/TitleTxt6Director of Manufacturing
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/FundraisingDirectExpensesAmt00
IRS990/FundraisingGrossIncomeAmt00
IRS990/GamingActivitiesInd0false
IRS990/GamingDirectExpensesAmt00
IRS990/GamingGrossIncomeAmt00
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantAmt00
IRS990/GrantsPayableGrp/BOYAmt00
IRS990/GrantsPayableGrp/EOYAmt00
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/TotalAmt00
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt01745170
IRS990/GrossSalesOfInventoryAmt00
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt01
IRS990/IndivRcvdGreaterThan100KCnt05
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt01419
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt026579
IRS990/InformationTechnologyGrp/TotalAmt027998
IRS990/InsuranceGrp/ManagementAndGeneralAmt09652
IRS990/InsuranceGrp/ProgramServicesAmt0109937
IRS990/InsuranceGrp/TotalAmt0119589
IRS990/IntangibleAssetsGrp/BOYAmt00
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/TotalAmt00
IRS990/InventoriesForSaleOrUseGrp/BOYAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt014
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt014
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt00
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt00
IRS990/IRPDocumentCnt08
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0671285
IRS990/LandBldgEquipBasisNetGrp/BOYAmt022583
IRS990/LandBldgEquipBasisNetGrp/EOYAmt024174
IRS990/LandBldgEquipCostOrOtherBssAmt0695459
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd0false
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt00
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt00
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE SPECIFIC AND PRIMARY PURPOSE AND CHARITABLE MISSION OF GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES IS TO CONDUCT RESEARCH ON AND DEVELOP VACCINES AND DIAGNOSTICS FOR LIFE-THREATENING INFECTIOUS DISEASES, INCLUDING HIV. GSID IS ALSO COMMITTED TO PROVIDE ASSISTANCE TO AND COLLABORATE WITH OTHER GLOBAL PUBLIC HEALTH ORGANIZATIONS, PRIVATE FOUNDATIONS, AND FOR-PROFIT ENTITIES FOCUSED ON PUBLIC HEALTH ISSUES, FOR THE PURPOSE OF FACILITATING ACCESS TO AFFORDABLE HEALTH SOLUTIONS WHICH BENEFIT THE PEOPLE IN DEVELOPING COUNTRIES, WHO ARE THE MOST IN NEED.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/MortgNotesPyblScrdInvstPropGrp/BOYAmt00
IRS990/MortgNotesPyblScrdInvstPropGrp/EOYAmt00
IRS990/NetAssetsOrFundBalancesBOYAmt0376516
IRS990/NetAssetsOrFundBalancesEOYAmt0448262
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt00
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/FundraisingAmt018268
IRS990/OccupancyGrp/ManagementAndGeneralAmt018268
IRS990/OccupancyGrp/ProgramServicesAmt0155855
IRS990/OccupancyGrp/TotalAmt0192391
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt08618
IRS990/OfficeExpensesGrp/ProgramServicesAmt08797
IRS990/OfficeExpensesGrp/TotalAmt017415
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt081500
IRS990/OtherAssetsTotalGrp/EOYAmt081500
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt09981
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt09981
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt082799
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0102761
IRS990/OtherExpensesGrp/Desc0VACCINE STORAGE & DISTRIBUTION
IRS990/OtherExpensesGrp/Desc1EQUIPMENT MAINTENANCE
IRS990/OtherExpensesGrp/Desc2PERMITS & REGISTRATION FEES
IRS990/OtherExpensesGrp/Desc3SUPPLIES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt01707
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt12143
IRS990/OtherExpensesGrp/ProgramServicesAmt049131
IRS990/OtherExpensesGrp/ProgramServicesAmt16894
IRS990/OtherExpensesGrp/TotalAmt049131
IRS990/OtherExpensesGrp/TotalAmt11707
IRS990/OtherExpensesGrp/TotalAmt22143
IRS990/OtherExpensesGrp/TotalAmt36894
IRS990/OtherLiabilitiesGrp/BOYAmt00
IRS990/OtherLiabilitiesGrp/EOYAmt08280
IRS990/OtherRevenueTotalAmt00
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt032983
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt032983
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0569865
IRS990/OtherSalariesAndWagesGrp/TotalAmt0635831
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt00
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt05183
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt05183
IRS990/PayrollTaxesGrp/ProgramServicesAmt041467
IRS990/PayrollTaxesGrp/TotalAmt051833
IRS990/PensionPlanContributionsGrp/FundraisingAmt01320
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt01320
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt022800
IRS990/PensionPlanContributionsGrp/TotalAmt025440
IRS990/PermanentlyRstrNetAssetsGrp/BOYAmt00
IRS990/PermanentlyRstrNetAssetsGrp/EOYAmt00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0316897
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0132135
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt00
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt05758
IRS990/PrincipalOfficerNm0CARTER A LEE
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0AIDS/VAX HIV VACCINE PROGRAM
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt010000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt010000
IRS990/ProgSrvcAccomActy2Grp/Desc0GSID is developing a system to rapidly diagnose and report the occurrence of infectious diseases in low resource point-of-care settings. The intent is to assist the healthcare provider by obtaining an accurate diagnosis so that the appropriate treatment is initiated quickly and information is communicated to governmental agencies and NGOs that formulate public health policy and allocate resources. In 2016, GSID personel conducted activities using its mobile-phone-based technology at public health centers in Zimbabwe. funding sources for the future. No activities in Sub-Saharan Africa took place during 2015.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt087036
IRS990/ProgSrvcAccomActy2Grp/GrantAmt00
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt00
IRS990/ProgSrvcAccomActy3Grp/Desc0In 2016, GSID provided consulting services to organizations supporting the development and manufacture of dengue fever and flu vaccines. Funding for this program is provided by the World Health Organization (Geneva, Switzerland). No activities were conducted by GSID personnel in Sub-Saharan Africa during 2016.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0629
IRS990/ProgSrvcAccomActy3Grp/GrantAmt00
IRS990/ProgSrvcAccomActy3Grp/RevenueAmt00
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01647375
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt0121
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt0624389
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt010450
IRS990/PYRevenuesLessExpensesAmt0-107521
IRS990/PYSalariesCompEmpBnftPaidAmt01141078
IRS990/PYTotalExpensesAmt01765467
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01657946
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvblFromDisqualifiedPrsnGrp/BOYAmt00
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReceivablesFromOfficersEtcGrp/BOYAmt00
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt071746
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/PersonalAmt00
IRS990/RentalIncomeOrLossGrp/RealAmt00
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0true
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt010000
IRS990/RoyaltiesGrp/TotalAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt025000
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01735156
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01647375
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01695422
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01969825
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01259464
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt08307242
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt014
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0121
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt065
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0158
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0535
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0893
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt074413
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.95590
IRS990ScheduleA/PublicSupportPY170Pct00.90449
IRS990ScheduleA/PublicSupportTotal170Amt07941720
IRS990ScheduleA/SubstantialContributorsTotAmt0365522
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01735156
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01647375
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01695422
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01969825
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01259464
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt08307242
IRS990ScheduleA/TotalSupportAmt08308135
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/EquipmentGrp/BookValueAmt021067
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0174147
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0195214
IRS990ScheduleD/FederalIncomeTaxLiabilityAmt00
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt02000
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0484962
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0486962
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt081500
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0LEASEHOLD SECURITY DEPOSIT
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt01107
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt012176
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt013283
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt08280
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0ACCRUED 401K MATCH
IRS990ScheduleD/TotalBookValueLandBuildingsAmt024174
IRS990ScheduleD/TotalBookValueOtherAssetsAmt081500
IRS990ScheduleD/TotalLiabilityAmt08280
IRS990ScheduleJ/AnyNonFixedPaymentsInd0false
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.00$0.00$0.10$0.10
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.21$0.00$0.21$0.02$0.35$0.33
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.54$0.00$0.54$0.81$0.80$0.01
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.53$0.01$0.52$0.96$1.04$0.08
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.61$0.01$0.60$1.34$1.06$0.28
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.35$0.01$0.34$1.13$1.04$0.09
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.25$0.01$0.24$0.93$1.08$0.15
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.41$0.01$0.40$1.44$1.52$0.08
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.48$0.01$0.48$1.72$1.69$0.03
2016Detailed filing. Detailed filing data is available for this year.$0.49$0.04$0.45$1.75$1.67$0.07
2015XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.42$0.04$0.38$1.66$1.77$0.11
2014Detailed filing. Detailed filing data is available for this year.$0.53$0.05$0.48$1.70$1.74$0.05
2013Detailed filing. Detailed filing data is available for this year.$0.57$0.04$0.53$1.98$1.87$0.11
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.04$0.42$1.54
2011Summary only. Only limited summary data is available for this year.$0.72$0.06$0.65$1.79$1.73$0.06
2010Summary only. Only limited summary data is available for this year.$0.65$0.06$0.59$2.18$2.53$0.34